Get in touch with the right contacts for all of our services.
National Cancer Institute Awards Nemours $4.65M for Community Oncology Research Program
Nemours one of two pediatric designees in U.S.
The National Cancer Institute’s Community Oncology Research Program (NCORP), a project of the National Institutes of Health, has granted a $4.65 million award to the Nemours Center for Cancer and Blood Disorders, led by E. Anders Kolb, MD. As such, Nemours is one of only two designated pediatric NCORPs in the U.S. The project encompasses activities in both Delaware – at Nemours/Alfred I. duPont Hospital for Children – and Florida.
The specific aims of NCORP are to increase community engagement in the care of patients with cancer and to better understand the science of delivering high quality care in the community setting, including treatment, symptom and pain management, and health outcomes of those affected. There is a particular focus on removing barriers to research participation and novel therapies for underserved populations. The principal investigator for the NCORP is Eric Sandler, MD.
The formation of a pediatric NCORP is uncommon, given that pediatric cancer is relatively rare and enrolling patients in significant numbers for studies can be challenging. Alignment of Nemours’ Delaware and Florida programs will enable greater enrollment and increase access to pediatric clinical oncology trials for a diverse population. The potential for positive impact is great given Nemours’ institutional commitment, capable leadership and investigative team, highly supportive research environment, and enterprise-wide access to patient records and clinical trial data.
The prestigious award recognizes Nemours’ oncology programs enterprise-wide and reflects its commitment to advancing new cancer treatments, family-centered care, and attention to psychosocial needs to reduce stress and improve outcomes.
Dr. Kolb said: “This award acknowledges Nemours as one of the nation’s top children’s health care providers and our multidisciplinary experts in cancer care as among the very best. The National Cancer Institute has selected Nemours as a leader in scientific discovery and in providing community-based, high quality cancer care. I am very proud of our team and this validation of their hard work and tireless dedication to children with cancer.”